Skip to main content
. 2020 Aug 24;35(7):588–597. doi: 10.1038/s41371-020-00405-3

Fig. 2. Partial effect plots for Model-2 and Model-3.

Fig. 2

CRP C-reactive protein, NLR neutrophil-to-lymphocyte ratio, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker.